Pharmasight
Sign inSee a worked packBook the bench
Ship · Generis

German pharma (500 users) implemented CARA for unified data management since 2022

CheplapharmShipGeneris

Cheplapharm german pharma (500 users) implemented CARA for unified data management since 2022.

Generis makes the CARA platform, the regulatory/quality/clinical content backbone used by major pharma companies, now with AI document-classification features built in.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.

Source

Published by Generis on its own site — read the original case study on caralifesciences.generiscorp.com ↗

More like this

Related use cases

  1. 01Migrated 900,000 regulatory documents from legacy Documentum to CARA, serving 85,000 usersBayerGenerisShip
  2. 02Consolidated 65 million documents (13 TB) across two repositories via CARA during ongoing archivingUnnamed global pharmaGenerisShip
  3. 03Unified 12 siloed systems (18 million documents) into one CARA instance for 85,000 usersMerckGenerisShip
  4. 04Integrated QMS, RIM, and safety processes on the CARA Life Sciences PlatformSwixx BiopharmaGenerisShip
  5. 05Transitioned from legacy systems to CARA for improved UX across global operations (Pfizer also separately reported consolidating 4 legacy systems / 18M docs / 40,000 usersPfizerGenerisShip
  6. 06Transforming content operations for 2x faster time to marketUCBVeeva SystemsShip